115717-83-4|AU 1421|5-Methyl-2-(2-(1-naphthyl)ethenyl)-4-piperidinopyridine hydrochloride|-范德生物科技公司

AU 1421

NMR下载 COA and HPLC MSDS下载
names：
5-Methyl-2-(2-(1-naphthyl)ethenyl)-4-piperidinopyridine hydrochloride
CAS号：
115717-83-4
MDL Number：
MF(分子式)： C23H25ClN2 MW(分子量)： 364.92
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	AU 1421
英文别名	AU 1421, AU1421, AU-1421
CAS号	115717-83-4
Inchi	1S/C23H24N2.ClH/c1-18-17-24-21(16-23(18)25-14-5-2-6-15-25)13-12-20-10-7-9-19-8-3-4-11-22(19)20;/h3-4,7-13,16-17H,2,5-6,14-15H2,1H3;1H/b13-12-;
InchiKey	FIRAEJACZMKMQE-USGGBSEESA-N
分子式 Formula	C23H25ClN2
分子量 Molecular Weight	364.92
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	AU 1421(CAS:115717-83-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	AU 1421 is a K(+)-site-directed pyridine derivative which activates hydrolysis of the K(+)-sensitive phosphoenzyme of sarcoplasmic reticulum Ca(2+)-ATPase and inactivates that of K(+)-transporting ATPases.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Nagamune H, Fukushima Y, Takada J, Yoshida K, Unami A, Shimooka T, Terada H. The lipophilic weak base (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421) is a potent protonophore type cationic uncoupler of oxidative phosphorylation in mitochondria. Biochim Biophys Acta. 1993 Mar 1;1141(2-3):231-7. PubMed PMID: 8382953.

[2]Fukushima Y, Asano S, Takada J. K(+)-site-directed pyridine derivative, AU-1421, activates hydrolysis of the K(+)-sensitive phosphoenzyme of sarcoplasmic reticulum Ca(2+)-ATPase and inactivates that of K(+)-transporting ATPases. Biochim Biophys Acta. 1992 Apr 29;1106(1):71-6. PubMed PMID: 1533792.

[3] Hioki Y, Takada J, Hidaka Y, Yano M. Environmental differences of a pyridine derivative (AU-1421)-access sites between (H+,K+)-ATPase and (Na+,K+)-ATPase. J Pharmacobiodyn. 1991 Mar;14(3):170-5. PubMed PMID: 1652636.

[4] Takada J, Hioki Y, Yano M. (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421), calcium ions and ethylenediamine as the K(+)-site directed probe for Na+/K(+)-ATPase. Biochim Biophys Acta. 1990 Nov 15;1041(2):123-8. PubMed PMID: 2176105.

[5] Takada J. Reversible inhibition of sodium and potassium-dependent adenosine triphosphatase by the pyridine derivative, AU-1421 during turnover cycle. Biochem Pharmacol. 1990 Oct 1;40(7):1527-31. PubMed PMID: 2171532.

6: Hioki Y, Takada J, Hidaka Y, Takeshita H, Hosoi M, Yano M. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor. Arch Int Pharmacodyn Ther. 1990 May-Jun;30

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开